We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKE icon
1801
Oneok
OKE
$54.5B
-2,001
Closed -$108K
OMCL icon
1802
Omnicell
OMCL
$1.68B
-2,113
Closed -$129K
OPBK icon
1803
OP Bancorp
OPBK
$233M
-605
Closed -$5K
OPCH icon
1804
Option Care Health
OPCH
$3.56B
-9,897
Closed -$141K
OPRA
1805
Opera Ltd
OPRA
$1.79B
-6,068
Closed -$34K
OR icon
1806
OR Royalties Inc
OR
$6.2B
-105,303
Closed -$924K
ORA icon
1807
Ormat Technologies
ORA
$6.65B
-1,043
Closed -$55K
ORI icon
1808
Old Republic International
ORI
$10.4B
-8,163
Closed -$168K
ORRF icon
1809
Orrstown Financial Services
ORRF
$838M
-3,612
Closed -$66K
OSK icon
1810
Oshkosh
OSK
$9.59B
-16,578
Closed -$1.02M
OTEX icon
1811
Open Text
OTEX
$6.04B
-2,100
Closed -$68K
OTLK icon
1812
Outlook Therapeutics
OTLK
$191M
-1,246
Closed -$100K
OTTR icon
1813
Otter Tail
OTTR
$3.94B
-982
Closed -$49K
OXM icon
1814
Oxford Industries
OXM
$552M
$0 ﹤0.01%
+1
New +$77
PAC icon
1815
Grupo Aeroportuario del Pacifico
PAC
$13.3B
-497
Closed -$41K
PACB icon
1816
Pacific Biosciences
PACB
$370M
-12,658
Closed -$94K
PAYX icon
1817
Paychex
PAYX
$42.7B
-1,052
Closed -$69K
PBH icon
1818
Prestige Consumer Healthcare
PBH
$2.6B
-38,027
Closed -$1.17M
PBPB
1819
DELISTED
Potbelly
PBPB
-7,154
Closed -$58K
PBYI icon
1820
Puma Biotechnology
PBYI
$454M
-5,942
Closed -$121K
PCG icon
1821
PG&E
PCG
$38.5B
-23,892
Closed -$567K
PEG icon
1822
Public Service Enterprise Group
PEG
$37.7B
-13,110
Closed -$682K
PEGA icon
1823
Pegasystems
PEGA
$5.38B
-63,996
Closed -$1.53M
PFGC icon
1824
Performance Food Group
PFGC
$18B
-31,010
Closed -$1M
PFS icon
1825
Provident Financial Services
PFS
$3.19B
-1,751
Closed -$42K

Similar funds

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.